Time to improve health-related quality of life outcomes in patients with acute promyelocytic leukemia

Blood. 2015 Nov 26;126(22):2523-4. doi: 10.1182/blood-2015-07-658922. Epub 2015 Oct 9.

Authors

Fabio Efficace¹, Franco Mandelli¹, Uwe Platzbecker², Francesco Cottone¹, Francesco Lo Coco³

Affiliations

¹ Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy.
² Department of Medicine I, University Hospital Dresden "Carl Gustav Carus," Dresden, Germany.
³ Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata, Roma, Italy.

PMID: 26453660
DOI: 10.1182/blood-2015-07-658922

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Arsenic Trioxide
Arsenicals / administration & dosage
Disease-Free Survival
Female
Humans
Leukemia, Promyelocytic, Acute / drug therapy*
Leukemia, Promyelocytic, Acute / mortality*
Male
Middle Aged
Oxides / administration & dosage
Quality of Life*
Survival Rate
Tretinoin / administration & dosage

Substances

Arsenicals
Oxides
Tretinoin
Arsenic Trioxide